By David Lock2007-10-12T09:00:00
The High Court hearing this year over the issue of the NHS funding drugs for treating Alzheimer's disease forced NICE to state its principles with great clarity. Now it has to stick to them, says David Lock
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud